-
Je něco špatně v tomto záznamu ?
Application of mass cytometry in multiparametric characterization of precancerous cervical lesions
E. Pešut, I. Šimić, D. Kužilkova, T. Kalina, R. Fureš, I. Erceg Ivkošić, N. Milutin Gašperov, I. Sabol
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
HRZZ-IP-2019-04-3403
Hrvatska Zaklada za Znanost
PubMed
39462866
DOI
10.1002/cyto.b.22211
Knihovny.cz E-zdroje
- MeSH
- cervix uteri patologie metabolismus MeSH
- dospělí MeSH
- dysplazie děložního hrdla diagnóza patologie MeSH
- infekce papilomavirem patologie diagnóza virologie MeSH
- Krüppel-like faktor 4 * MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádorové biomarkery * genetika metabolismus MeSH
- nádory děložního čípku * diagnóza patologie genetika MeSH
- prekancerózy * patologie diagnóza MeSH
- průtoková cytometrie * metody MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Cervical cancer (CC) is the fourth most common malignant tumor in women worldwide. Detecting different biomarkers together on single cells by novel method mass cytometry could contribute to more precise screening. Liquid-based cytology (LBC) cervical samples were collected (N = 53) from women categorized as normal and precancerous lesions. Human papillomavirus was genotyped by polymerase chain reaction, while simultaneous examination of the expression of 29 proteins was done by mass cytometry (CyTOF). Differences in cluster abundances were assessed with Spearman's rank correlation as well as high dimensional data analysis (t-SNE, FlowSOM). Cytokeratin (ITGA6, Ck5, Ck10/13, Ck14, Ck7) expression patterns allowed determining the presence of different cells in the cervical epithelium. FlowSOM analysis enabled to phenotype cervical cells in five different metaclusters and find new markers that could be important in CC screening. The markers Ck18, Ck18, and CD63 (Metacluster 3) showed significantly increasing associated with severity of the precancerous lesions (Spearman rank correlation rho 0.304, p = 0.0271), while CD71, KLF4, LRIG1, E-cadherin, Nanog and p53 (Metacluster 1) decreased with severity of the precancerous lesions (Spearman rank correlation rho -0.401, p = 0.0029). Other metaclusters did not show significant correlation, but metacluster 2 (Ck17, MCM, MMP7, CD29, E-cadherin, Nanog, p53) showed higher abundance in low- and high-grade intraepithelial lesion cases. CyTOF appears feasible and should be considered when examining novel biomarkers on cervical LBC samples. This study enabled us to characterize different cells in the cervical epithelium and find markers and populations that could distinguish precancerous lesions.
Division of Molecular Medicine Ruđer Bošković Institute Zagreb Croatia
Faculty of Dental Medicine and Health Josip Juraj Strossmayer University Osijek Osijek Croatia
Special Hospital Sveta Katarina Department of Women's Health Zagreb Croatia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25010494
- 003
- CZ-PrNML
- 005
- 20250429135115.0
- 007
- ta
- 008
- 250415s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/cyto.b.22211 $2 doi
- 035 __
- $a (PubMed)39462866
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Pešut, Ena $u Division of Molecular Medicine, Ruđer Bošković Institute, Zagreb, Croatia $1 https://orcid.org/0000000154096034
- 245 10
- $a Application of mass cytometry in multiparametric characterization of precancerous cervical lesions / $c E. Pešut, I. Šimić, D. Kužilkova, T. Kalina, R. Fureš, I. Erceg Ivkošić, N. Milutin Gašperov, I. Sabol
- 520 9_
- $a Cervical cancer (CC) is the fourth most common malignant tumor in women worldwide. Detecting different biomarkers together on single cells by novel method mass cytometry could contribute to more precise screening. Liquid-based cytology (LBC) cervical samples were collected (N = 53) from women categorized as normal and precancerous lesions. Human papillomavirus was genotyped by polymerase chain reaction, while simultaneous examination of the expression of 29 proteins was done by mass cytometry (CyTOF). Differences in cluster abundances were assessed with Spearman's rank correlation as well as high dimensional data analysis (t-SNE, FlowSOM). Cytokeratin (ITGA6, Ck5, Ck10/13, Ck14, Ck7) expression patterns allowed determining the presence of different cells in the cervical epithelium. FlowSOM analysis enabled to phenotype cervical cells in five different metaclusters and find new markers that could be important in CC screening. The markers Ck18, Ck18, and CD63 (Metacluster 3) showed significantly increasing associated with severity of the precancerous lesions (Spearman rank correlation rho 0.304, p = 0.0271), while CD71, KLF4, LRIG1, E-cadherin, Nanog and p53 (Metacluster 1) decreased with severity of the precancerous lesions (Spearman rank correlation rho -0.401, p = 0.0029). Other metaclusters did not show significant correlation, but metacluster 2 (Ck17, MCM, MMP7, CD29, E-cadherin, Nanog, p53) showed higher abundance in low- and high-grade intraepithelial lesion cases. CyTOF appears feasible and should be considered when examining novel biomarkers on cervical LBC samples. This study enabled us to characterize different cells in the cervical epithelium and find markers and populations that could distinguish precancerous lesions.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a nádory děložního čípku $x diagnóza $x patologie $x genetika $7 D002583
- 650 12
- $a prekancerózy $x patologie $x diagnóza $7 D011230
- 650 12
- $a Krüppel-like faktor 4 $7 D000090062
- 650 12
- $a nádorové biomarkery $x genetika $x metabolismus $7 D014408
- 650 12
- $a průtoková cytometrie $x metody $7 D005434
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a infekce papilomavirem $x patologie $x diagnóza $x virologie $7 D030361
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a cervix uteri $x patologie $x metabolismus $7 D002584
- 650 _2
- $a dysplazie děložního hrdla $x diagnóza $x patologie $7 D002578
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Šimić, Ivana $u Division of Molecular Medicine, Ruđer Bošković Institute, Zagreb, Croatia $1 https://orcid.org/0000000278163534
- 700 1_
- $a Kužilkova, Daniela $u CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia $1 https://orcid.org/0000000180869790
- 700 1_
- $a Kalina, Tomáš $u CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia $1 https://orcid.org/0000000344752872 $7 xx0060125
- 700 1_
- $a Fureš, Rajko $u General Hospital Zabok and Veterans Affairs Hospital, Department of Gynecology and Obstetrics, Zabok, Croatia $u Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University Osijek, Osijek, Croatia $1 https://orcid.org/0000000164940972
- 700 1_
- $a Erceg Ivkošić, Ivana $u Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University Osijek, Osijek, Croatia $u Special Hospital Sveta Katarina, Department of Women's Health, Zagreb, Croatia $1 https://orcid.org/0000000161251864
- 700 1_
- $a Milutin Gašperov, Nina $u Division of Molecular Medicine, Ruđer Bošković Institute, Zagreb, Croatia $1 https://orcid.org/0000000262197836
- 700 1_
- $a Sabol, Ivan $u Division of Molecular Medicine, Ruđer Bošković Institute, Zagreb, Croatia $1 https://orcid.org/0000000257538528
- 773 0_
- $w MED00013936 $t Cytometry. Part B, Clinical cytometry $x 1552-4957 $g Roč. 108, č. 1 (2025), s. 55-66
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39462866 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429135110 $b ABA008
- 999 __
- $a ok $b bmc $g 2311700 $s 1247575
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 108 $c 1 $d 55-66 $e 20241027 $i 1552-4957 $m Cytometry. Part B, Clinical cytometry $n Cytometry B Clin Cytom $x MED00013936
- GRA __
- $a HRZZ-IP-2019-04-3403 $p Hrvatska Zaklada za Znanost
- LZP __
- $a Pubmed-20250415